Kozni ambulance Fialova s.r.o.
- Address
- Evropska 1724/59, Dejvice, 160 00 Prague, Czechia
Kozni ambulance Fialova s.r.o. - Dermatological Research Center
Kozni ambulance Fialova s.r.o. is a specialized dermatological research center with extensive experience in evaluating novel therapeutic interventions for inflammatory and autoimmune skin conditions. The center demonstrates particular expertise in conducting Phase 2 and Phase 3 clinical trials for moderate-to-severe dermatological disorders, with a strong focus on immune-mediated conditions requiring advanced biologic and targeted systemic therapies.
- Atopic dermatitis research, including multiple biologics and novel immunomodulatory agents (amlitelimab, dupilumab, lunsekimig, ATI-045, APG777)
- Autoimmune skin diseases, including chronic spontaneous urticaria, cutaneous lupus erythematosus, and plaque psoriasis
- Hair disorders and inflammatory dermatoses, particularly alopecia areata and lichen simplex chronicus (neurodermatitis)
The center has established comprehensive capabilities in assessing both efficacy and safety outcomes for biologic therapies and Janus kinase (JAK) inhibitors in dermatology. Their research portfolio includes long-term extension studies and dose-ranging trials, demonstrating capacity for complex study designs that evaluate maintenance therapy, treatment withdrawal strategies, and optimal dosing regimens. The facility serves patients aged 12 years and older, with particular emphasis on conditions inadequately controlled by conventional topical therapies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kozni ambulance Fialova s.r.o.
lock Showing 1 of 15 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) | Amgen Inc. | Phase III | Not Recruiting | Oct 2023 | Jun 2026 |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amlitelimab | 4 | Unknown | 2022-11-10 | 2024-10-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.